What is the future for fragment-based drug discovery? - Wikidata - awgldk - TriplyDB

What is the future for fragment-based drug discovery?

What is the future for fragment-based drug discovery?

http://www.wikidata.org/entity/Q38644516

about

Insights into the Impact of Linker Flexibility and Fragment Ionization on the Design of CK2 Allosteric Inhibitors: Comparative Molecular Dynamics Simulation Studies.

P2860

Q47200403-CC0D218C-1B43-4871-8A4F-F44D1C67A0EE

P2860

What is the future for fragment-based drug discovery?

http://www.wikidata.org/entity/Q38644516

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

What is the future for fragment-based drug discovery?

@en

type

label

What is the future for fragment-based drug discovery?

@en

prefLabel

What is the future for fragment-based drug discovery?

@en

P1433

Q38644516-63A981AF-7E4D-41FA-AE17-7F1B8817FA74

P1476

Q38644516-D6397D69-12D2-4A51-81C8-D9E18B79B5B2

P2093

Q38644516-6F3FE8CA-2406-40F3-B8A9-7FD9F5B3E66E

P2860

Q38644516-0E45D05A-8612-4B71-A76D-51058CE5D58E

Q38644516-2041B8CD-BD45-472D-979C-0E66E7B89F58

Q38644516-2F1AD880-077C-4A39-9010-B9C33E665023

Q38644516-34101AB7-BD6A-43F2-A581-C4B8D6020990

Q38644516-36C95F95-00D2-4DAF-B666-1754E5ED3ECC

Q38644516-3F5709DA-1854-4622-9833-A70B183924EE

Q38644516-4E087638-161B-440D-AC87-B05241E8629E

Q38644516-663ED0DB-D154-41A1-B81E-751620D8B9F3

Q38644516-6BCADA21-8BF9-4B26-B352-1F7023FD4833

Q38644516-6CA23F22-C3C8-4EB4-8C92-55C0AB7FDD35

P304

Q38644516-0395187A-3B40-49FF-9AC3-31829484C61F

P31

Q38644516-462BA49F-80B9-46FB-9D6E-E2081C25741D

Q38644516-ddee4da7-4339-4b51-8365-c32ff33d389c

P356

Q38644516-7B9B990F-EBA0-4F76-8E0A-0E994783FC4B

P433

Q38644516-04368E2A-4AF3-4992-8BF9-18468A2DFF70

P478

Q38644516-F4DBBE16-1698-4CBF-8098-297196E16854

P50

Q38644516-075A27B1-5901-4808-A677-2644BB8EB999

P577

Q38644516-6FF6C99D-838D-4156-B668-C75EE672A45C

P698

Q38644516-0488E5ED-F02F-40F8-B2B2-869FB1DBDE2C

P356

P1433

Future Medicinal Chemistry

P1476

What is the future for fragment-based drug discovery?

@en

P2093

Michael M Hann

http://www.w3.org/2001/XMLSchema#string

P2860

Natural-product-derived fragments for fragment-based ligand discovery

Fragment-Linking Approach Using (19)F NMR Spectroscopy To Obtain Highly Potent and Selective Inhibitors of β-Secretase

Fragment Linking and Optimization of Inhibitors of the Aspartic Protease Endothiapepsin: Fragment-Based Drug Design Facilitated by Dynamic Combinatorial Chemistry

Detection of secondary binding sites in proteins using fragment screening

Thermodynamics of fragment binding.

Discovery of selective small-molecule activators of a bacterial glycoside hydrolase.

Fragment-based hit identification: thinking in 3D.

Multiple fragment docking and linking in primary and secondary pockets of dopamine receptors.

Ligand deconstruction: Why some fragment binding positions are conserved and others are not

Small molecules, big targets: drug discovery faces the protein-protein interaction challenge.

P304

1457-1460

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/FMC-2017-0106

http://www.w3.org/2001/XMLSchema#string

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28795595

http://www.w3.org/2001/XMLSchema#string